Amanote Research
Register
Sign In
Rituximab Induces Remission in Refractory HCV Associated Cryoglobulinaemic Vasculitis
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/ard.2002.004929
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
December 1, 2003
Authors
P Lamprecht
Publisher
BMJ
Related search
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Kidney International Reports
Nephrology
Complete Remission Induced by Rituximab in Refractory, Seronegative, Muscle-Specific, Kinase-Positive Myasthenia Gravis
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Microscopic Haematuria in ANCA-Associated Vasculitis With Glomerulonephritis During Treatment and Remission
Journal of Vasculitis
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Activation-Induced Cytidine Deaminase in B Cells of Hepatits C Virus-Related Cryoglobulinaemic Vasculitis
Clinical and Experimental Immunology
Allergy
Immunology
Two Cases of Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Internal Medicine
Internal Medicine
Medicine
Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab
BMJ Case Reports
Medicine
Rituximab for Refractory Wegener's Granulomatosis
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
